Back to stocks
ENGNW
enGene Therapeutics Inc.• Healthcare
Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
6
Partial Q3 2026
Total 13F value
$2.3M
Filed positions so far
New positions
2
This quarter
Sold positions
1
This quarter
Top holders
Institutions with disclosed positions in this stock
| Fund | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
Peapod Lane Capital Llc | $2.1M | 1.04M | 1.55% | -5.8% |
Pfs Partners, Llc | $80K | 40.0K | 0.03% | +263.6% |
Indivisible Partners | $59K | 29.4K | 0.00% | New Position |
Covestor Ltd | $43K | 21.5K | 0.03% | New Position |
Farther Finance Advisors, Llc | $200 | 100 | 0.00% | Unchanged |
Sbi Securities Co., Ltd. | $56 | 28 | 0.00% | Unchanged |